This report presents findings from an analysis of the Medicare Part D marketplace in 2013 and changes in drug coverage and costs since 2006. It presents key findings related to Medicare drug plan availability, enrollment, premiums, low-income subsidies, the coverage gap, benefit design, cost sharing, formularies, and utilization management, based on data from CMS for all plans participating in Part D. The analysis was conducted jointly by researchers at Georgetown University, the Kaiser Family Foundation and the National Opinion Research Center at the University of Chicago.
MedicareSee more about Medicare
- state & global data
- view as grid
- view as list
Sustaining Medicare for the Future: What’s Next In the Debt-Reduction Debate? Briefing and Panel Discussion
As Washington continues to search for long-term solutions to reduce federal spending, with Medicare often at the forefront of these discussions, the Kaiser Family Foundation held a policy briefing Wednesday, Jan. 30, at 9:30 a.m. to explore options that could be considered to reduce Medicare spending, and their implications for…
Healthier and Wealthier, or Sicker and Poorer? Prospects for Medicare Beneficiaries Now and in the Future
This January 2014 briefing, co-sponsored by the Kaiser Family Foundation and the Alliance for Health Reform, examines what is known about the health and economic security of Medicare beneficiaries today, as well as how current and future beneficiaries may be affected by the leading proposals that aim to achieve Medicare savings.
This analysis finds that relatively few Medicare beneficiaries have switched Part D prescription drug plans voluntarily during the annual open enrollment period — even though those who do switch often lower their out-of-pocket costs as a result of changing plans. The vast majority (87% on average between 2006 and 2010) stayed in the same Part D plan, even though the plans can change premiums, deductibles, cost-sharing amounts, and their list of covered drugs each year. Higher rates of plan switching were observed in PDPs that increased premiums, increased deductibles, or dropped coverage of brand-name drugs in the coverage gap.
The 2014 Part D Data Spotlight analyzes information about the Medicare Part D stand-alone prescription drug plan (PDP) options available to beneficiaries in 2014. The analysis shows that Medicare beneficiaries on average will have a choice of 35 stand-alone prescription drug plans in 2014, and somewhat more “benchmark” plans available to Low-Income Subsidy (LIS) beneficiaries nationwide. The weighted average premium will increase by 5 percent between 2013 and 2014 if enrollees remain in the same plans next year. The analysis also finds more plans are using preferred pharmacy networks and adopting a growing number of cost-sharing formulary tiers for different drugs.
Si usted tiene Medicare, su cobertura de salud no tiene cambios como consecuencia del Obamacare. Usted puede seguir confiando en el Medicare para ayudar a pagar su hospital, doctores y otros gastos médicos. Usted todavía tiene la opción de elegir entre el Medicare tradicional o el Medicare Advantage Plan (como…
This July 22, 2013 briefing, Streamlining Cost Sharing in Medicare: The Impact on Beneficiaries, explored the impact on beneficiaries of recent proposals to combine the two main parts of Medicare.
This report examines Medicare beneficiaries’ out-of-pocket health care costs, which comprise a significant share of their household expenses.
Wide Disparities in the Income and Assets of People on Medicare by Race and Ethnicity: Now and in the Future
This report examines the income, savings, and home equity of current and future Medicare beneficiaries, focusing on racial/ethnic disparities. The report finds that these differences in the financial well-being of white, black and Hispanic beneficiaries persist across age, education level, marital status, and other demographic factors.
This Data Spotlight provides an overview of Medicare Advantage enrollment patterns in March 2013, and examines variations by plan type, state, and firm. It also analyzes trends in premiums paid by beneficiaries enrolled in Medicare Advantage plans, including variations by plan type, and describes the out-of-pocket limits and prescription drug coverage in the Part D “donut hole” provided by the plans in 2013.